resorcinol has been researched along with Ache in 4 studies
resorcinol: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7951
resorcinol : A benzenediol that is benzene dihydroxylated at positions 1 and 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Topical resorcinol 15% is a self-treatment for painful hidradenitis suppurativa nodules and abscesses with good results in reducing pain and lesion duration." | 8.12 | Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa. ( Barros-Tornay, R; Calleja-Hernández, MÁ; Cameán-Fenández, M; Cordero-Ramos, J; Delgado-Valverde, M; Merino-Bohórquez, V, 2022) |
| "Topical treatment with 15% resorcinol reduced pain from painful nodules in all patients with HS." | 7.76 | Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa. ( Boer, J; Jemec, GB, 2010) |
| "Topical resorcinol 15% is a self-treatment for painful hidradenitis suppurativa nodules and abscesses with good results in reducing pain and lesion duration." | 4.12 | Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa. ( Barros-Tornay, R; Calleja-Hernández, MÁ; Cameán-Fenández, M; Cordero-Ramos, J; Delgado-Valverde, M; Merino-Bohórquez, V, 2022) |
| "Topical treatment with 15% resorcinol reduced pain from painful nodules in all patients with HS." | 3.76 | Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa. ( Boer, J; Jemec, GB, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cordero-Ramos, J | 1 |
| Merino-Bohórquez, V | 1 |
| Delgado-Valverde, M | 1 |
| Barros-Tornay, R | 1 |
| Cameán-Fenández, M | 1 |
| Calleja-Hernández, MÁ | 1 |
| Brizzi, A | 2 |
| Aiello, F | 1 |
| Marini, P | 1 |
| Cascio, MG | 2 |
| Corelli, F | 1 |
| Brizzi, V | 2 |
| De Petrocellis, L | 1 |
| Ligresti, A | 1 |
| Luongo, L | 1 |
| Lamponi, S | 1 |
| Maione, S | 2 |
| Pertwee, RG | 1 |
| Di Marzo, V | 2 |
| Boer, J | 1 |
| Jemec, GB | 1 |
| Bisogno, T | 1 |
| Palazzo, E | 1 |
| Thomas, A | 1 |
| van der Stelt, M | 1 |
| de Novellis, V | 1 |
| Marabese, I | 1 |
| Ross, R | 1 |
| van de Doelen, T | 1 |
| Pertwee, R | 1 |
4 other studies available for resorcinol and Ache
| Article | Year |
|---|---|
Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa.
Topics: Aluminum; Amber; Chemical Phenomena; Drug Stability; Emulsions; Hidradenitis Suppurativa; Humans; Pa | 2022 |
Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist.
Topics: Analgesics; Animals; Calcium Channels; Cell Survival; Cells, Cultured; CHO Cells; Cricetulus; Dose-R | 2014 |
Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa.
Topics: Adult; Drug Administration Schedule; Female; Hidradenitis Suppurativa; Humans; Middle Aged; Pain; Pa | 2010 |
In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands.
Topics: Action Potentials; Adenylyl Cyclases; Amides; Analgesics; Animals; Brain Stem; CHO Cells; Cricetinae | 2006 |